4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-051303
Director sold 5,100 shares at $3.19 ($16,269)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2022-09-22 | Sale | −5,100 | $3.19 | $16,269 | 228,179 | D: show line 1 in the form |
| Open-market sales · 5,100 sh · avg $3.19 · $16,269 | |||||||
Loading xslF345X03/doc4.xml…